NCT02964078 2026-02-10Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed27 enrolled 10 charts
NCT03091192 2026-01-23Savolitinib vs. Sunitinib in MET-driven PRCC.AstraZenecaPhase 3 Active not recruiting60 enrolled 15 charts